GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,580.00
Bid: 12,578.00
Ask: 12,582.00
Change: -10.00 (-0.08%)
Spread: 4.00 (0.032%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Europe recasts COVID-19 vaccine playbook after first-round flop

Thu, 01st Apr 2021 18:37

* For a graphic on vaccine roll-out, see: https://tmsnrt.rs/3fzstuP

By John Miller and Ludwig Burger

ZURICH, April 1 (Reuters) - Europe, under fire for fumbling
its vaccine roll-out and fighting a fresh wave of infections, is
scrambling to speed up the pace of injections and avoid being
left further behind by Britain and the United States.

In Paris, the city's hallowed national soccer stadium is
being transformed into a mass vaccination hub, while Italy -
with 20,000 infections daily - has put the army and civil
defence agency in charge, after new Prime Minister Mario Draghi
fired the country's vaccine czar.

Over Easter, Germany's North Rhine-Westphalia state is
relaxing rules on who can get 450,000 doses of AstraZeneca's
vaccine. Clotting concerns have prompted the country to
limit the vaccine to people over the age of 60, but North
Rhine-Westphalia hopes its measures will now allow more people
in that age group to get a first dose.

Originally, it had wanted to give the AstraZeneca vaccine to
pregnant women and their partners, among other priority groups.

"We can't do that anymore, because I assume that those
people ... are under 60," North Rhine Westphalia's Health
Minister Karl-Josef Laumann told reporters.

"We didn't want to bunker these shots, we decided we would
get them via vaccination centres to people as quickly as
possible."

Europe's urgency to reverse what the World Health
Organization branded on Thursday an "unacceptably slow" start to
vaccinations is growing, as variants first detected in Britain,
South Africa and now Brazil whip up angst that acting too slowly
will let the virus proliferate again.

The chaos of Europe's roll-out has been exacerbated by
squabbling over vaccine exports, health concerns over
AstraZeneca's vaccine and some temporary delivery delays
affecting Pfizer, Moderna and AstraZeneca
vaccines.

The European Union was slower than Britain and the United
States, not only to order vaccines last year from companies but
also in approving them. Even once they were approved,
vaccination rates have been disappointing.

The WHO estimates just 4% of 750 million people in 53
countries across continental Europe, from wealthier Scandinavia
to poorer Balkan countries, have been fully vaccinated, a
quarter of the U.S. count.

While the European Union's vaccination rate is slowly
climbing, only 13.4% of adults in the bloc have had at least one
shot, according to Europe's vaccine tracker.

By contrast, more than half of adult Britons and 38% of U.S.
adults have received at least one dose, official figures and
Reuters calculations show.

Still, the situation is improving: A Reuters analysis shows
the seven-day average for the four largest countries - Germany,
France, Italy and Spain - was at its highest yet during the last
week.

Since Spain resumed AstraZeneca shots on March 24 after
suspending them temporarily over clotting concerns, its
seven-day rolling average of vaccinations rose to nearly 200,000
shots a day, from 95,283 daily a week earlier, Spanish officials
said.

The country is now converting venues like conference centres
and, like France, football stadiums, into mass vaccination
centres, and expects to inoculate 70% of its 47 million
population by the end of summer.

Spanish Health Minister Carolina Darias has said that April
will be "an inflection point", as more vaccines flood into the
country.

The EU expects a major ramp-up of deliveries in the second
quarter will be sufficient to inoculate at least 255 million
people, or 70% of its adult population, by July.

About 200 million doses of Pfizer-BioNTech's vaccine are due
in the quarter, enough for 100 million people, while deliveries
of Johnson & Johnson's single-dose shot will start this
month.

VETS, DENTISTS, COMPANIES

France is also converting veterinarian and dentists' offices
into vaccine centres, while Italy has abandoned primrose-shaped
pavilions in its squares and is getting doctors, dentists and
pharmacists to dispense doses instead. The aim is to more than
double daily vaccinations to half a million from 230,000
currently.

Pharmacies in Switzerland are also preparing to start
offering doses to people over 65 this month, but the government
expects that once mass vaccinations become possible, likely
sometime in May, private companies will have a role, similar to
flu clinics some offer each year to employees.

The Swiss government expects 10.5 million doses by July,
enough for roughly 5.2 million people.

"There won't just be shots in vaccination centres, doctors
and pharmacists," Swiss Health Minister Alain Berset said on
Wednesday. "That's something we're hoping for, something we're
supporting."

(Reporting by John Miller in Zurich, Ludwig Burger in
Frankfurt, Emilio Parodi in Milan, Francesco Guarascio in
Brussels, Matthias Blamont in Paris, Maria Sheahan in Berlin,
Nathan Allen in Madrid;
Editing by Josephine Mason and Susan Fenton)

More News
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.